MATES SHARON (Chairman, President & CEO) exercised options at INTRA-CELLULAR THERAPIES, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 3/4/2025ACC: 0000950170-25-032587
DirectorOfficer· Chairman, President & CEO
Since Dec 2018
-16.98K
Net shares
Net seller
$2.18M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
34.97K acquired · 51.95K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+34.97K
Price / share
—
Trade value
—
% of position
3.2%
3/1/2025
1.09M→1.12M
Common Stock
Direct
Shares
−16.98K
Price / share
$128.20
Trade value
$2.18M
% of position
1.5%
3/1/2025
1.12M→1.10M
Total
Net shares
+17.99K
Net value
-$2.18M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | M · Option Exercise | +34.97K | — | — | 3.2% | 1.09M | 1.12M |
| Common Stock Direct | 3/1/2025 | F · Tax Withholding | −16.98K | $128.20 | $2.18M | 1.5% | 1.12M | 1.10M |
| Total | +17.99K | -$2.18M | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
34.97K shares
Shares
−34.97K
Strike price
Held after
69.94K
Exercisable
—
3/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock34.97K shares | 3/1/2025 | M · Option Exercise | −34.97K | — | 69.94K |